The role of the COMT Val158 met polymorphism in the phenotypic expression of obsessive-compulsive disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 1, 2010, Pages 167-176

  Katerberg, Hilga ^a,b   Cath, Danielle C ^b   Denys, Damiaan A J P ^c   Heutink, Peter ^b,d   Polman, Annemiek ^a   Van Nieuwerburgh, Filip C W ^e   Deforce, Dieter L D ^e   Bochdanovits, Zoltán ^b,d   Van Balkom, Anton J L M ^b   Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

Age of onset; COMT; OC symptom dimensions; OC symptom severity; OCD

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; FACTOR ANALYSIS, STATISTICAL; FEMALE; GENOTYPE; HUMANS; MALE; METHIONINE; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; POLYMORPHISM, GENETIC; VALINE;

EID: 73949160967     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30971     Document Type: Article

References (64)

1. Alsobrook IJ, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL. 1999. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet (Neuropsychiatr Genet) 88:669-675.
2. Alsobrook JP II, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. 2002. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet (Neuropsychiatr Genet) 114:116-120.
3. American Psychiatric Association. 1994. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington DC:American Psychiatric Association.
4. Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, Rossler W. 2004. Obsessive-compulsive severity spectrum in the community: Prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci 254:156-164.
5. Azzam A, Mathews CA. 2003. Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive-compulsive disorder. Am J Med Genet (Neuropsychiatr Genet) 123:64-69.
6. Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. 2002. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet (Neuropsychiatr Genet) 114:347-353.
7. Chabane N, Delorme R, Millet B, Mouren MC, Leboyer M, Pauls D. 2005. Early-onset obsessive-compulsive disorder: A subgroup with a specific clinical and familial pattern? J Child Psychol Psychiatry 46:881-887.
8. Chen J, Lipska BK, Halim N,MaQD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, HermanMM,Apud J, Egan MF, Kleinman JE, Weinberger DR. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
9. Delorme R,Golmard JL, Chabane N, Millet B, KrebsMO,Mouren-Simeoni MC, Leboyer M. 2005. Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med 35:237-243.
10. DeMille MM, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi A, Okonofua F, Grigorenko E, Schulz LO, Bonne-Tamir B, Lu RB, Parnas J, Pakstis AJ, Kidd KK. 2002. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet 111:521-537.
11. Denys D, de Geus F, van Megen HJ, Westenberg HG. 2004a. Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res 128:273-280.
12. Denys D, Zohar J, Westenberg HG. 2004b. The role of dopamine in obsessive-compulsive disorder: Preclinical and clinical evidence. J Clin Psychiatry 65 Suppl 14:11-17.
13. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H. 2006. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol 16:446-450.
14. Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, Derici E, Camdeviren H. 2003. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety 18:41-45.
15. First MB, Spitzer RL, Gobbon M, Williams JBW. 1998. Structured Clinical Interview for DSM-IV Axis 1 Disorders - Patient edition (SCID-I/P, Version 2.0, 8/98 revision). New York: Biometrics Department, New York State Psychiatric Institute.
16. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. 1998. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 95:9991-9996.
17. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. 1989a. The Yale - Brown obsessive compulsive Scale. II. validity. Arch Gen Psychiatry 46:1012-1016.
18. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. 1989b. The Yale-Brown obsessive compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011.
19. Haasio K, Huotari M, Nissinen E, Mannisto PT. 2003. Tissue histopathology, clinical chemistry and behaviour of adult Comt-gene-disrupted mice. J Appl Toxicol 23:213-219.
20. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, Leventhal BL, Cook EH Jr. 2002. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet (Neuropsychiatr Genet) 114:541-552.
21. Hanna GL, Veenstra-Vanderweele J, Cox NJ, Van Etten M, Fischer DJ, Himle JA, Bivens NC,WuX, Roe CA, Hennessy KA, Dickel DE, Leventhal BL, CookEHJr. 2007. Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder. Biol Psychiatry 62:856-862.
22. Hasler G, Kazuba D, Murphy DL. 2006. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am J Med Genet (Neuropsychiatr Genet) 141:403-408.
23. Hasler G, Pinto A, Greenberg BD, Samuels J, Fyer AJ, Pauls D, Knowles JA, McCracken JT, Piacentini J, Riddle MA, Rauch SL, Rasmussen SA, Willour VL, Grados MA, Cullen B, Bienvenu OJ, Shugart YY, Liang KY, Hoehn-Saric R, Wang Y, Ronquillo J, Nestadt G, Murphy DL. 2007. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD collaborative genetics study. Biol Psychiatry 61:617-625.
24. Hemmings SM, Stein DJ. 2006. The current status of association studies in obsessive-compulsive disorder. Psychiatr Clin North Am 29:411-444.
25. Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568-1578.
26. Hill RA, McInnes KJ, Gong EC, Jones ME, Simpson ER, Boon WC. 2007. Estrogen deficient male mice develop compulsive behavior. Biol Psychiatry 61:359-366.
27. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA. 1997. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A 94:4572-4575.
28. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178-1189.
29. Katerberg H, Delucchi KL, Denys DAJP, Stewart SE, Stack DE, de Geus F, VulinkNCC,FluitmanSBAHA,den Boer JA, van BalkomAJLM, Smit JH, van Oppen P, Polman A, Jenike MA, Mathews CA, Cath DC. Categorical versus item-level factor analysis of obsessive compulsive symptoms: A one factor model? (submitted).
30. Kim SJ, Lee HS, Kim CH. 2005. Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology 52:176-182.
31. Labad J, Menchon JM, Alonso P, Segalas C, Jimenez S, Vallejo J. 2005. Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry 66:428-435 quiz 546.
32. Labad J,MenchonJM, Alonso P, Segalas C, Jimenez S, Jaurrieta N, Leckman JF, Vallejo J. 2008. Gender differences in obsessive-compulsive symptom dimensions. Depress Anxiety 25:832-838.
33. Lachman HM,Papolos DF, Saito T,YuYM,Szumlanski CL, Weinshilboum RM. 1996. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
34. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL. 1997. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 154:911-917.
35. Lochner C, Hemmings SM, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA, Niehaus DJ, Stein DJ. 2004. Corrigendum to "Gender in obsessive-compulsive disorder: Clinical and genetic findings" [Eur. Neuropsychopharmacol. 14 (2004) 105-113]. Eur Neuropsychopharmacol 14:437-445.
36. Lochner C, Kinnear CJ, Hemmings SM, Seller C, Niehaus DJ, Knowles JA, Daniels W, Moolman-Smook JC, Seedat S, Stein DJ. 2005. Hoarding in obsessive-compulsive disorder: Clinical and genetic correlates. J Clin Psychiatry 66:1155-1160.
37. Lochner C, Hemmings SM, Kinnear CJ, Nel D, Seedat S, Moolman-Smook JC, Stein DJ. 2008. Cluster analysis of obsessive-compulsive symptomatology: Identifying obsessive-compulsive disorder subtypes. Isr J Pyschiatry Relat Sci 45:164-176.
38. MacCallum RC, Widaman KF, Zhang S,Hong S. 1999. Sample size in factor analysis. Psychol Methods 4:84-99.
39. Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK, Rasmussen SA, Jenike MA. 2002. Symptom stability in adult obsessive-compulsive disorder: Data from a naturalistic two-year follow-up study. Am J Psychiatry 159:263-268.
40. Mataix-Cols D, Rosario-Campos MC, Leckman JF. 2005. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 162:228-238.
41. Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. 2004. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav 3:75-79.
42. Meulenbelt I, Droog S, Trommelen GJ, Boomsma DI, Slagboom PE. 1995. High-yield noninvasive human genomic DNA isolation method for genetic studies in geographically dispersed families and populations. Am J Hum Genet 57:1252-1254.
43. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
44. Niehaus DJ, Kinnear CJ, Corfield VA, du Toit PL, van Kradenburg J, Moolman-Smook JC, Weyers JB, Potgieter A, Seedat S, Emsley RA, Knowles JA, Brink PA, Stein DJ. 2001. Association between a catechol-o-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. J Affect Disord 65:61-6165.
45. Ohara K, Nagai M, Suzuki Y, Ochiai M. 1998. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 80:145-148.
46. Pinto A, Eisen JL, Mancebo MC, Greenberg BD, Stout RL, Rasmussen SA. 2007. Taboo thoughts and doubt/checking: A refinement of the factor structure for obsessive-compulsive disorder symptoms. Psychiatry Res 151:255-258.
47. Pooley EC, Fineberg N, Harrison PJ. 2007. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Mol Psychiatry 12:556-561.
48. Poyurovsky M, Michaelovsky E, Frisch A, Knoll G, Amir I, Finkel B, Buniak F, Hermesh H, Weizman R. 2005. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: A case-control study. Neurosci Lett 389:21-24.
49. Pritchard JK, Donnelly P. 2001. Case-control studies of association in structured or admixed populations. Theor Popul Biol 60:227-237.
50. Purcell S, Cherny SS, Sham PC. 2003. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150.
51. R Development Core Team. 2008. R: A language and environment for statistical computing. Vienna, Austria, R Foundation for Statistical Computing. http://www.R-project.org.
52. Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, Katsovich L, Scahill L, King RA, Woody SR, Tolin D, Hollander E, Kano Y, Leckman JF. 2006. The dimensional Yale - Brown obsessive-compulsive scale (DY-BOCS): An instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry 11:495-504.
53. Schindler KM, Richter MA, Kennedy JL, Pato MT, Pato CN. 2000. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet (Neuropsychiatr Genet) 96:721-724.
54. Schulze TG, McMahon FJ. 2002. Genetic association mapping at the crossroads: Which test and why? Overview and practical guidelines. Am J Med Genet (Neuropsychiatr Genet) 114:1-11.
55. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl20): 22-33, quiz 34-57.
56. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-VanetikM,KnoblerHY, Shinar E,Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296-1302.
57. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, RiddleMA,Nestadt G. 2006.Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11:763-770.
58. Thomas DC, Witte JS. 2002. Point: Population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11:505-512.
59. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. 2005. Twin studies on obsessive-compulsive disorder: A review. Twin Res Hum Genet 8:450-458.
60. Vulink NC, Denys D, Bus L, Westenberg HG.2006. Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol 21:171-175.
61. Walitza S, Scherag A, Renner TJ, Hinney A, Remschmidt H, Herpertz-Dahlmann B, Schulz E, Schafer H, Lange KW, Wewetzer C, Gerlach M. 2008. Transmission disequilibrium studies in early onset of obsessivecompulsive disorder for polymorphisms in genes of the dopaminergic system. J Neural Transm 115:1071-1078.
62. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickramaratne PJ, Wittchen HU, Yeh EK. 1994. The cross national epidemiology of obsessive compulsive disorder. The cross national collaborative group. J Clin Psychiatry 55(Suppl):5-10.
63. Williams KE, Koran LM. 1997. Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 58:330-334, quiz 335-336.
64. Zinkstok J, Nimwegen L, Amelsvoort T, Haan L, Yusuf MA, Baas F, Linszen D. 2008. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: Preliminary results. Psychiatry Res 157:1-8.